Impact of environmental factors and physical activity on disability and quality of life in CIDP.

CIDP Chronic inflammatory demyelinating polyradiculoneuropathy Disability Epidemiology Physical activity Quality of life

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 08 03 2020
accepted: 13 05 2020
revised: 11 05 2020
pubmed: 21 5 2020
medline: 22 6 2021
entrez: 21 5 2020
Statut: ppublish

Résumé

A few observational studies and randomized trials suggest that exercise and rehabilitation may improve activity limitation and quality of life (QoL) in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but the impact of other modifiable factors on the severity of the disease is not well understood. Using a structured questionnaire, we collected data on lifestyle and dietary habits of the patients included in the Italian CIDP database to investigate the possible influence of modifiable lifestyle factors on disability and QoL. Questionnaire data were available for 323 patients. The effect of lifestyle and dietary exposures on impairment, disability and QoL was evaluated using logistic regression models, adjusting for age, sex, disease duration, physical activity and smoking. Physical activity was associated with lower sensory impairment by the ISS scale, less disability by the INCAT and RODS scale and a better QoL in all the domains of EURO-QoL scale with the exception of anxiety/depression. None of the other parameters had an impact on these scales. This study adds evidence to the possible role of physical activity in improving symptom severity, disability and QoL in patients with CIDP. None of the other environmental factors investigated appeared to have an impact on the severity and health perception of CIDP.

Identifiants

pubmed: 32430573
doi: 10.1007/s00415-020-09916-y
pii: 10.1007/s00415-020-09916-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2683-2691

Investigateurs

Pietro Emiliano Doneddu (PE)
Giuseppe Liberatore (G)
Francesca Gallia (F)
Eduardo Nobile-Orazio (E)
Erdita Peci (E)
Dario Cocito (D)
Daniele Velardo (D)
Stefano Tronci (S)
Raffaella Fazio (R)
Fiore Manganelli (F)
Emanuele Spina (E)
Antonietta Topa (A)
Lucio Santoro (L)
Marta Ruiz (M)
Chiara Briani (C)
Stefano Cotti-Piccinelli (S)
Alice Todeschini (A)
Massimiliano Filosto (M)
Corrado Cabona (C)
Angela Zuppa (A)
Luana Benedetti (L)
Antonio Toscano (A)
Luca Gentile (L)
Anna Mazzeo (A)
Giorgia Mataluni (G)
Girolama Alessandra Marfia (GA)
Giuseppe Cosentino (G)
Laura Piccolo (L)
Ilaria Callegari (I)
Andrea Cortese (A)
Elena Pinuccia Verrengia (EP)
Stefano Jann (S)
Elisa Bianchi (E)
Ettore Beghi (E)
Angelo Maurizio Clerici (AM)
Federica Scrascia (F)
Marinella Carpo (M)
Martina Garnero (M)
Angelo Schenone (A)
Marco Luigetti (M)
Mario Sabatelli (M)
Patrizia Dacci (P)
Giuseppe Lauria (G)
Luca Leonardi (L)
Giovanni Antonini (G)
Tiziana Rosso (T)
Erika Schirinzi (E)
Gabriele Siciliano (G)
Claudia Balducci (C)
Guido Cavaletti (G)

Auteurs

Pietro Emiliano Doneddu (PE)

Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.

Elisa Bianchi (E)

Laboratorio di Malattie Neurologiche, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Dario Cocito (D)

Istituti Clinici Scientifici Maugeri, Turin, Italy.

Fiore Manganelli (F)

Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.

Raffaella Fazio (R)

Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Milan, Italy.

Massimiliano Filosto (M)

Center for Neuromuscular Diseases and Neuropathies, Unit of Neurology, ASST 'Spedali Civili', University of Brescia, Brescia, Italy.

Ettore Beghi (E)

Laboratorio di Malattie Neurologiche, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Anna Mazzeo (A)

Department of Clinical and Experimental Medicine, Unit of Neurology, University of Messina, Messina, Italy.

Giuseppe Cosentino (G)

University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Andrea Cortese (A)

University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Stefano Jann (S)

Department of Neuroscience, Niguarda Ca' Granda Hospital, Milan, Italy.

Angelo Maurizio Clerici (AM)

Neurology Unit, Circolo and Macchi Foundation Hospital, DBSV, Insubria University, Varese, Italy.

Giovanni Antonini (G)

Department of Neurology Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Unit of Neuromuscular Diseases, 'Sapienza' University of Rome, Sant'Andrea Hospital, Rome, Italy.

Gabriele Siciliano (G)

Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy.

Girolama Alessandra Marfia (GA)

Department of Systems Medicine, Dysimmune Neuropathies Unit, Tor Vergata University of Rome, Rome, Italy.

Chiara Briani (C)

Department of Neuroscience, Neurology Unit, University of Padua, Padua, Italy.

Giuseppe Lauria (G)

Unit of Neuroalgology, IRCCS Foundation 'Carlo Besta' Neurological Institute, Milan, Italy.
Department of Biomedical and Clinical Sciences 'Luigi Sacco', University of Milan, Milan, Italy.

Tiziana Rosso (T)

ULSS2 Marca Trevigiana, UOC Neurologia-Castelfranco Veneto, Treviso, Italy.

Guido Cavaletti (G)

School of Medicine and Surgery and Experimental Neurology Unit, University of Milano-Bicocca, Monza, Italy.

Marinella Carpo (M)

ASST Bergamo Ovest-Ospedale Treviglio, Treviglio, Italy.

Luana Benedetti (L)

IRCCS Ospedale Policlinico San Martino Genova, Genoa, Italy.

Angelo Schenone (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy.

Giuseppe Liberatore (G)

Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.

Erdita Peci (E)

Department of Neuroscience, University of Turin, Turin, Italy.

Emanuele Spina (E)

Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.

Stefano Tronci (S)

Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Milan, Italy.

Stefano Cotti Piccinelli (S)

Center for Neuromuscular Diseases and Neuropathies, Unit of Neurology, ASST 'Spedali Civili', University of Brescia, Brescia, Italy.

Antonio Toscano (A)

Department of Clinical and Experimental Medicine, Unit of Neurology, University of Messina, Messina, Italy.

Luca Gentile (L)

Department of Clinical and Experimental Medicine, Unit of Neurology, University of Messina, Messina, Italy.

Laura Piccolo (L)

University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Luca Leonardi (L)

Department of Neurology Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Unit of Neuromuscular Diseases, 'Sapienza' University of Rome, Sant'Andrea Hospital, Rome, Italy.

Giorgia Mataluni (G)

Department of Systems Medicine, Dysimmune Neuropathies Unit, Tor Vergata University of Rome, Rome, Italy.

Marta Ruiz (M)

Department of Neuroscience, Neurology Unit, University of Padua, Padua, Italy.

Mario Sabatelli (M)

Università Cattolica del Sacro Cuore. Sede di Roma, Rome, Italy.
Centro Clinico NEMO Adulti, Rome, Italy.

Lucio Santoro (L)

Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.

Eduardo Nobile-Orazio (E)

Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy. eduardo.nobile@unimi.it.
Department of Medical Biotechnology and Translational Medicine (BIOMETRA), Milan University, Milan, Italy. eduardo.nobile@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH